BioCentury
ARTICLE | Clinical News

Zilver PTX regulatory update

August 17, 2009 7:00 AM UTC

Cook said it received CE Mark approval last month for its Zilver PTX drug-eluting peripheral stent to treat peripheral artery disease (PAD) affecting the superficial femoral artery (SFA). The company ...